Ray Summit 2026 opens today in San Francisco as the first-ever vLLM Conference runs concurrently under the same roof. The ...

This transcript was created using speech recognition software. While it has been reviewed by human transcribers, it may contain errors. Please review the episode audio before quoting from this ...

It's not common for someone to find a python in their backyard or garage in Florida, but if they do there are steps to follow ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

On Tuesday, the AI company Recursive Superintelligence announced a $410 million compute deal with Amazon Web Services. The company, which emerged from stealth in May with $650 million in funding, is ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

OpenAI is giving 100,000 academic researchers free access to its frontier models through 2027. The same week, it detailed how it slashed the cost of running its agents, including a model that used ...

In this post, we will discuss how you can delete browsing history using CMD in Chrome, Edge, or Firefox. These browsers store your activity history to improve your browsing experience. The history and ...

With nearly two decades of retail management and project management experience, Brett Day can simplify complex traditional and Agile project management philosophies and methodologies and can explain ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

View the basic RXRX option chain and compare options of Recursion Pharmaceuticals, Inc. on Yahoo Finance.

Recursion Pharmaceuticals insiders reported 6 transactions totaling $589,430.56. Activity included 2 tax payments, 2 sales, and 2 stock awards between July and August 2026. View more Major Holders ...